LFVN has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
LFVN has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companyยs financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | No Debt |
LFVN's Cash to Debt is ranked higher than
73% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 16.56 vs. LFVN: No Debt ) |
LFVN'
s 10-Year Cash to Debt Range
Min: 1.12 Max: No Debt Current: No Debt |
| Interest Coverage | No Debt |
LFVN's Interest Coverage is ranked higher than
76% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 66.20 vs. LFVN: No Debt ) |
LFVN'
s 10-Year Interest Coverage Range
Min: 488 Max: No Debt Current: No Debt |
| F-Score: 4 |
|
| Z-Score: 11.84 |
|
| M-Score: -2.87 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ยย3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 11.30 |
LFVN's Operating margin (%) is ranked higher than
69% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 5.10 vs. LFVN: 11.30 ) |
LFVN'
s 10-Year Operating margin (%) Range
Min: -188.5 Max: 17 Current: 11.3 |
| Net-margin (%) | 2.3 |
LFVN's Net-margin (%) is ranked higher than
69% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 2.15 vs. LFVN: 2.3 ) |
LFVN'
s 10-Year Net-margin (%) Range
Min: -247.3 Max: 9.9 Current: 2.3 |
| Revenue Growth (%) | 66.8 |
LFVN's Revenue Growth (%) is ranked higher than
98% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 2.40 vs. LFVN: 66.8 ) |
LFVN'
s 10-Year Revenue Growth (%) Range
Min: -25.2 Max: 80.9 Current: 66.8 |
| Joel Greenblatt 446,875 sh (New) | Arnold Van Den Berg 170,180 sh (unchged) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Joel Greenblatt | 2013-03-31 | New Buy | 0.05% | $2.16 - $2.9 | $ 2.44 | -1% | 446875 | |
| Arnold Van Den Berg | 2012-12-31 | Add 221.09% | 0.03% | $1.73 - $3.38 | $ 2.44 | -11% | 170180 | |
| Arnold Van Den Berg | 2012-06-30 | Reduce -27.4% | 0.01% | $2.59 - $3.83 | $ 2.44 | -24% | 53000 | |
| Arnold Van Den Berg | 2012-03-31 | Reduce -29.13% | $1.7 - $56.31 | $ 2.44 | -68% | 73000 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 24.90 |
LFVN's P/E(ttm) is ranked higher than
72% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 20.95 vs. LFVN: 24.90 ) |
LFVN'
s 10-Year P/E(ttm) Range
Min: 3.22 Max: 156.11 Current: 24.9 |
| P/S | 1.53 |
LFVN's P/S is ranked higher than
56% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 2.22 vs. LFVN: 1.53 ) |
LFVN'
s 10-Year P/S Range
Min: 0.67 Max: 14 Current: 1.53 |
| PFCF | 34.86 |
LFVN's PFCF is ranked higher than
60% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 19.30 vs. LFVN: 34.86 ) |
LFVN'
s 10-Year PFCF Range
Min: 10 Max: 325 Current: 34.86 |
| EV-to-EBIT | 13.19 |
LFVN's EV-to-EBIT is ranked higher than
77% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 17.90 vs. LFVN: 13.19 ) |
LFVN'
s 10-Year EV-to-EBIT Range
Min: 10.7 Max: 93.4 Current: 13.19 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Earnings Yield (Greenblatt) | 7.60 |
LFVN's Earnings Yield (Greenblatt) is ranked higher than
81% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 5.60 vs. LFVN: 7.60 ) |
LFVN'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1 Max: 9.4 Current: 7.6 |
| Forward Rate of Return (Yacktman) | -0.2 |
LFVN's Forward Rate of Return (Yacktman) is ranked higher than
98% of the 90 Companies in the Global Diagnostics & Research industry. ( Industry Median: 0.46 vs. LFVN: -0.2 ) |
LFVN'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: -11.5 Max: -0.9 Current: -0.2 |
| Industry: | Diagnostics & Research |
|---|---|
| Compare: | LH, ALR, DGX, LIFE, ENZ |